Frontiers | Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer | Immunology
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
IJMS | Free Full-Text | Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma | HTML
Biologics for Asthma and Risk of Infection - Immunology and Allergy Clinics
IJMS | Free Full-Text | Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma | HTML
Cureus | Review of Prominent Cytokines as Superior Therapeutic Targets for Moderate-to-Severe Atopic Dermatitis
Tezspire: Effective Treatment for Severe Uncontrolled Asthma | BioPharma Media
Tezepelumab as an Emerging Therapeutic Option for the Treatment of Sev | DDDT
Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses - ScienceDirect
New and Anticipated Therapies for Severe Asthma - The Journal of Allergy and Clinical Immunology: In Practice
IJMS | Free Full-Text | Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma | HTML
Mechanism of action by which tezepelumab improves clinical outcomes in... | Download Scientific Diagram
Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma | Nature Communications
Tezepelumab - an overview | ScienceDirect Topics
Report: Tezepelumab reduces severe asthma exacerbations, but unlikely to be cost-effective
Biomedicines | Free Full-Text | Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma | HTML
Frontiers | Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer | Immunology
Frontiers | Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer | Immunology
Mechanism of action by which tezepelumab improves clinical outcomes in... | Download Scientific Diagram
Strategies for choosing a biologic for your patient with allergy or asthma - Annals of Allergy, Asthma & Immunology
Potential new targets for drug development in severe asthma - World Allergy Organization Journal
Tezspire (tezepelumab-ekko) for the Treatment of Severe Asthma, USA
Selecting the right biologic for your patients with severe asthma - Annals of Allergy, Asthma & Immunology
Tezepelumab - Wikipedia
Tezepelumab Overview - Creative Biolabs
